Top

Quality of Life Research

Gepubliceerd in:

12-08-2021

What conservative interventions can improve the long-term quality of life, depression, and anxiety of individuals with stable COPD? A systematic review and meta-analysis

Auteurs: Zejun Liang, Qian Wang, Chenying Fu, Rui Liu, Lu Wang, Gaiqin Pei, Lin Xu, Chengqi He, Quan Wei

Gepubliceerd in: Quality of Life Research | Uitgave 4/2022

Abstract

Purpose

Many conservative interventions are used in the management of stable chronic obstructive pulmonary disease (COPD). It could be helpful for the prescribers to know what the evidence suggests about the effects of these interventions on the long-term quality of life (QoL), depression, and anxiety. This study aimed to summarize the rationale for the use of conservative interventions to improve the long-term QoL, depression, and anxiety in patients with stable COPD.

Methods

The MEDLINE, Embase, Cochrane Library, and Web of Science databases were searched from database inception to December 2019. Randomized clinical trials (RCTs) investigating the long-term effects of conservative interventions on three parameters, including QoL, depression, and anxiety in patients with COPD were eligible for further analysis. To improve methodological rigor, only RCTs examining these parameters as primary outcomes were included. The standardized mean differences (SMD) with 95% confidence intervals (CIs) were calculated using random effects models. Quality of evidence was rated using the updated version of Van Tulder’s criteria.

Results

Thirty-eight RCTs were identified. Regarding long-term depression, there was moderate evidence supporting cognitive behavioral therapy compared with usual care in patients with COPD; regarding the long-term QoL of patients with COPD, there was limited evidence supporting walking programs, supplementary sugarcane bagasse dietary fiber, roflumilast, and tiotropium.

Conclusions

Cognitive behavioral therapy is effective in alleviating the long-term depression of patients with COPD. Evidence for other interventions was insufficient, making it difficult to draw conclusions in terms of their effectiveness on the long-term QoL, depression, and anxiety.

vorige artikel Correction to: Efficacy of physical therapy interventions on quality of life and upper quadrant pain severity in women with post-mastectomy pain syndrome: a systematic review and meta-analysis

volgende artikel Quality of life of parents with children with congenital abnormalities: a systematic review with meta-analysis of assessment methods and levels of quality of life

Alleen toegankelijk voor geautoriseerde gebruikers

Singh, D., Agusti, A., Anzueto, A., Barnes, P. J., Bourbeau, J., Celli, B. R., Criner, G. J., Frith, P., Halpin, D., Han, M., López Varela, M. V., Martinez, F., Montes de Oca, M., Papi, A., Pavord, I. D., Roche, N., Sin, D. D., Stockley, R., Vestbo, J., Wedzicha, J. A., & Vogelmeier, C. (2019). Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease: The GOLD science committee report 2019. The European respiratory journal, 53(5), 1900164. https://doi.org/10.1183/13993003.00164-2019.CrossRefPubMed

Di Marco, F., Verga, M., Reggente, M., Maria Casanova, F., Santus, P., Blasi, F., Allegra, L., & Centanni, S. (2006). Anxiety and depression in COPD patients: The roles of gender and disease severity. Respiratory Medicine, 100(10), 1767–1774. https://doi.org/10.1016/j.rmed.2006.01.026CrossRefPubMed

Atlantis, E., Fahey, P., Cochrane, B., & Smith, S. (2013). Bidirectional associations between clinically relevant depression or anxiety and COPD: A systematic review and meta-analysis. Chest, 144(3), 766–777. https://doi.org/10.1378/chest.12-1911CrossRefPubMed

Franssen, F. M. E., Smid, D. E., Deeg, D. J. H., Huisman, M., Poppelaars, J., Wouters, E. F. M., & Spruit, M. A. (2018). The physical, mental, and social impact of COPD in a population-based sample: Results from the Longitudinal Aging Study Amsterdam. NPJ Primary Care Respiratory Medicine, 28(1), 30. https://doi.org/10.1038/s41533-018-0097-3CrossRefPubMedPubMedCentral

Pumar, M. I., Gray, C. R., Walsh, J. R., Yang, I. A., Rolls, T. A., & Ward, D. L. (2014). Anxiety and depression—Important psychological comorbidities of COPD. Journal of Thoracic Disease, 6(11), 1615–1631. https://doi.org/10.3978/j.issn.2072-1439.2014.09.28CrossRefPubMedPubMedCentral

Maurer, J., Rebbapragada, V., Borson, S., Goldstein, R., Kunik, M. E., Yohannes, A. M., & Hanania, N. A. (2008). Anxiety and depression in COPD: Current understanding, unanswered questions, and research needs. Chest, 134(4 Suppl), 43s–56s. https://doi.org/10.1378/chest.08-0342CrossRefPubMed

Huang, J., Bian, Y., Zhao, Y., Jin, Z., Liu, L., & Li, G. (2021). The impact of depression and anxiety on chronic obstructive pulmonary disease acute exacerbations: A prospective cohort study. Journal of Affective Disorders, 281, 147–152. https://doi.org/10.1016/j.jad.2020.12.030CrossRefPubMed

Yohannes, A. M., & Alexopoulos, G. S. (2014). Depression and anxiety in patients with COPD. European Respiratory Review, 23(133), 345–349. https://doi.org/10.1183/09059180.00007813CrossRefPubMedPubMedCentral

Janson, C., Marks, G., Buist, S., Gnatiuc, L., Gislason, T., McBurnie, M. A., Nielsen, R., Studnicka, M., Toelle, B., Benediktsdottir, B., & Burney, P. (2013). The impact of COPD on health status: Findings from the BOLD study. European Respiratory Journal, 42(6), 1472–1483. https://doi.org/10.1183/09031936.00153712CrossRef

10.

Tsiligianni, I., Kocks, J., Tzanakis, N., Siafakas, N., & van der Molen, T. (2011). Factors that influence disease-specific quality of life or health status in patients with COPD: A review and meta-analysis of Pearson correlations. Primary Care Respiratory Journal, 20(3), 257–268. https://doi.org/10.4104/pcrj.2011.00029CrossRefPubMed

11.

Moher, D., Shamseer, L., Clarke, M., Ghersi, D., Liberati, A., Petticrew, M., Shekelle, P., & Stewart, L. A. (2015). Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Systematic Reviews, 4(1), 1. https://doi.org/10.1186/2046-4053-4-1CrossRefPubMedPubMedCentral

12.

Andrade, C. (2015). The primary outcome measure and its importance in clinical trials. The Journal of clinical psychiatry, 76(10), e1320–e1323. https://doi.org/10.4088/JCP.15f10377.CrossRefPubMed

13.

Maher, C. G., Sherrington, C., Herbert, R. D., Moseley, A. M., & Elkins, M. (2003). Reliability of the PEDro scale for rating quality of randomized controlled trials. Physical Therapy, 83(8), 713–721.CrossRef

14.

Higgins, J. P. T., Thomas, J., Chandler, J., Cumpston, M., Li, T., Page, M. J., Welch, V. A. (Editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.2 (updated February 2021). Cochrane, 2021. Available from https://www.training.cochrane.org/handbook.

15.

Review Manager (RevMan) [Computer program]. Version 5.4. In. (2020). The Cochrane Collaboration.

16.

Van Tulder, M., Furlan, A., Bombardier, C., & Bouter, L. (2003). Updated method guidelines for systematic reviews in the Cochrane collaboration back review group. Spine, 28(12), 1290–1299.PubMed

17.

Rabe, K. F., Bateman, E. D., O’Donnell, D., Witte, S., Bredenbroker, D., & Bethke, T. D. (2005). Roflumilast—An oral anti-inflammatory treatment for chronic obstructive pulmonary disease: A randomised controlled trial. The Lancet, 366(9485), 563–571. https://doi.org/10.1016/s0140-6736(05)67100-0CrossRef

18.

Shergis, J. L., Thien, F., Worsnop, C. J., Lin, L., Zhang, A. L., Wu, L., Chen, Y., Xu, Y., Langton, D., Da Costa, C., Fong, H., Wu, D., Story, D., & Xue, C. C. (2019). 12-month randomised controlled trial of ginseng extract for moderate COPD [Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non‐U.S. Gov’t]. Thorax, 74(6), 539–545. https://doi.org/10.1136/thoraxjnl-2018-212665CrossRefPubMed

19.

Lipson, D. A., Barnacle, H., Birk, R., Brealey, N., Locantore, N., Lomas, D. A., Ludwig-Sengpiel, A., Mohindra, R., Tabberer, M., Zhu, C. Q., & Pascoe, S. J. (2017). FULFIL Trial: Once-daily triple therapy for patients with chronic obstructive pulmonary disease [Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non‐U.S. Gov’t]. American Journal of Respiratory and Critical Care Medicine, 196(4), 438–446. https://doi.org/10.1164/rccm.201703-0449OCCrossRefPubMed

20.

Liu, M., Zheng, F., Ni, L., Sun, Y., Wu, R., Zhang, T., Zhang, J., Zhong, X., & Li, Y. (2016). Sugarcane bagasse dietary fiber as an adjuvant therapy for stable chronic obstructive pulmonary disease: A four-center, randomized, double-blind, placebo-controlled study [Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non‐U.S. Gov’t]. Journal of Traditional Chinese Medicine = Chung i tsa chih ying wen pan, 36(4), 418–426. https://doi.org/10.1016/s0254-6272(16)30057-7CrossRefPubMed

21.

Wootton, S. L., Cindy Ng, L. W., McKeough, Z. J., Jenkins, S., Hill, K., Eastwood, P. R., Hillman, D. R., Cecins, N., Spencer, L. M., Jenkins, C., & Alison, J. A. (2014). Ground-based walking training improves quality of life and exercise capacity in COPD. European Respiratory Journal, 44(4), 885–894.CrossRef

22.

Wootton, S. L., McKeough, Z., Ng, C. L. W., Jenkins, S., Hill, K., Eastwood, P. R., Hillman, D., Jenkins, C., Cecins, N., Spencer, L., & Alison, J. (2018). Effect on health-related quality of life of ongoing feedback during a 12-month maintenance walking programme in patients with COPD: A randomized controlled trial. Respirology, 23(1), 60–67. https://doi.org/10.1111/resp.13128CrossRefPubMed

23.

Duiverman, M. L., Wempe, J. B., Bladder, G., Vonk, J. M., Zijlstra, J. G., Kerstjens, H. A., & Wijkstra, P. J. (2011). Two-year home-based nocturnal noninvasive ventilation added to rehabilitation in chronic obstructive pulmonary disease patients: A randomized controlled trial [Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non‐U.S. Gov’t]. Respiratory research, 12, 112. https://doi.org/10.1186/1465-9921-12-112CrossRefPubMedPubMedCentral

24.

Heslop-Marshall, K., Baker, C., Carrick-Sen, D., Newton, J., Echevarria, C., Stenton, C., Jambon, M., Gray, J., Pearce, K., Burns, G., & De Soyza, A. (2018). Randomised controlled trial of cognitive behavioural therapy in COPD. ERJ Open Research. https://doi.org/10.1183/23120541.00094-2018CrossRefPubMedPubMedCentral

25.

Jolly, K., Sidhu, M. S., Hewitt, C. A., Coventry, P. A., Daley, A., Jordan, R., Heneghan, C., Singh, S., Ives, N., Adab, P., Jowett, S., Varghese, J., Nunan, D., Ahmed, K., Dowson, L., & Fitzmaurice, D. (2018). Self management of patients with mild COPD in primary care: Randomised controlled trial [Clinical Trial, Phase III; Journal Article; Multicenter Study; Pragmatic Clinical Trial; Research Support, Non‐U.S. Gov’t]. BMJ (Clinical Research ed.), 361, k2241. https://doi.org/10.1136/bmj.k2241CrossRef

26.

Wang, G., Liu, B., Cao, Y., Du, Y., Zhang, H., Luo, Q., Li, B., Wu, J., Lv, Y., Sun, J., Jin, H., Wei, K., Zhao, Z., Kong, L., Zhou, X., Miao, Q., Wang, G., Zhou, Q., & Dong, J. (2014). Effects of two Chinese herbal formulae for the treatment of moderate to severe stable chronic obstructive pulmonary disease: A multicenter, double-blind, randomized controlled trial. PLoS ONE, 9(8), e103168.CrossRef

27.

Tonnel, A. B., Perez, T., Grosbois, J. M., Verkindre, C., Bravo, M. L., & Brun, M. (2008). Effect of tiotropium on health-related quality of life as a primary efficacy endpoint in COPD. International Journal of COPD, 3(2), 301–310.CrossRef

28.

van Wetering, C. R., Hoogendoorn, M., Mol, S. J., Rutten-van Molken, M. P., & Schols, A. M. (2010). Short- and long-term efficacy of a community-based COPD management programme in less advanced COPD: A randomised controlled trial. Thorax, 65(1), 7–13. https://doi.org/10.1136/thx.2009.118620CrossRefPubMed

29.

Walker, P. P., Pompilio, P. P., Zanaboni, P., Bergmo, T. S., Prikk, K., Malinovschi, A., Montserrat, J. M., Middlemass, J., Šonc, S., Munaro, G., Marušič, D., Sepper, R., Niroshan Siriwardena, A., Calverley, P. M. A., & Dellaca’, C. R. L. (2018). Telemonitoring in chronic obstructive pulmonary disease (CHROMED). A randomized clinical trial [Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non‐U.S. Gov’t]. American Journal of Respiratory and Critical Care Medicine, 198(5), 620–628. https://doi.org/10.1164/rccm.201712-2404OCCrossRefPubMed

30.

Zarghami, M., Taghizadeh, F., Sharifpour, A., & Alipour, A. (2018). Efficacy of smoking cessation on stress, anxiety, and depression in smokers with chronic obstructive pulmonary disease: A randomized controlled clinical trial. Addiction and Health, 10(3), 137–147. https://doi.org/10.22122/ahj.v10i3.600CrossRefPubMedPubMedCentral

31.

Buhl, R., Gessner, C., Schuermann, W., Foerster, K., Sieder, C., Hiltl, S., & Korn, S. (2015). Efficacy and safety of once-daily QVA149 compared with the free combination of once-daily tiotropium plus twice-daily formoterol in patients with moderate-to-severe COPD (QUANTIFY): A randomised, non-inferiority study. Thorax, 70(4), 311. https://doi.org/10.1136/thoraxjnl-2014-206345CrossRefPubMed

32.

Chan, A. W., Lee, A., Lee, D. T., Sit, J. W., & Chair, S. Y. (2013). Evaluation of the sustaining effects of Tai Chi Qigong in the sixth month in promoting psychosocial health in COPD patients: A single-blind, randomized controlled trial [Journal Article; Randomized Controlled Trial; Research Support, Non‐U.S. Gov’t]. The Scientific World Journal, 2013, 425082. https://doi.org/10.1155/2013/425082CrossRefPubMedPubMedCentral

33.

Farmer, A., Williams, V., Velardo, C., Shah, S. A., Yu, L. M., Rutter, H., Jones, L., Williams, N., Heneghan, C., Price, J., Hardinge, M., & Tarassenko, L. (2017). Self-management support using a digital health system compared with usual care for chronic obstructive pulmonary disease: Randomized controlled trial. Journal of Medical Internet Research, 19(5), e144. https://doi.org/10.2196/jmir.7116CrossRefPubMedPubMedCentral

34.

Gallefoss, F., Bakke, P. S., & Kjaersgaard, P. (1999). Quality of life assessment after patient education in a randomized controlled study on asthma and chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine, 159(3), 812–817. https://doi.org/10.1164/ajrccm.159.3.9804047CrossRefPubMed

35.

Haugen, T. S., & Stavem, K. (2007). Rehabilitation in a warm versus a colder climate in chronic obstructive pulmonary disease—A randomized study. Journal of Cardiopulmonary Rehabilitation and Prevention, 27(1), 50–56.CrossRef

36.

Lamers, F., Jonkers, C. C., Bosma, H., Chavannes, N. H., Knottnerus, J. A., & van Eijk, J. T. (2010). Improving quality of life in depressed COPD patients: Effectiveness of a minimal psychological intervention [Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non‐U.S. Gov’t]. COPD, 7(5), 315–322. https://doi.org/10.3109/15412555.2010.510156CrossRefPubMed

37.

Moy, M. L., Martinez, C. H., Kadri, R., Roman, P., Holleman, R. G., Kim, H. M., Nguyen, H. Q., Cohen, M. D., Goodrich, D. E., Giardino, N. D., & Richardson, C. R. (2016). Long-term effects of an internet-mediated pedometer-based walking program for chronic obstructive pulmonary disease: Randomized controlled trial [Journal Article; Randomized Controlled Trial]. Journal of Medical Internet Research, 18(8), e215. https://doi.org/10.2196/jmir.5622CrossRefPubMedPubMedCentral

38.

Muhamad, R., Draman, N., Aziz, A. A., Abdullah, S., & Jaeb, M. Z. M. (2018). The effect of Tualang honey on the quality of life of patients with chronic obstructive pulmonary disease: A randomized controlled trial. Journal of Taibah University Medical Sciences, 13(1), 42–50.CrossRef

39.

Polkey, M. I., Qiu, Z. H., Zhou, L., Zhu, M. D., Wu, Y. X., Chen, Y. Y., Ye, S. P., He, Y. S., Jiang, M., He, B. T., Mehta, B., Zhong, N. S., & Luo, Y. M. (2018). Tai Chi and pulmonary rehabilitation compared for treatment-naive patients with COPD: A randomized controlled trial [Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non‐U.S. Gov’t]. Chest, 153(5), 1116–1124. https://doi.org/10.1016/j.chest.2018.01.053CrossRefPubMed

40.

Pumar, M. I., Roll, M., Fung, P., Rolls, T. A., Walsh, J. R., Bowman, R. V., Fong, K. M., & Yang, I. A. (2019). Cognitive behavioural therapy (CBT) for patients with chronic lung disease and psychological comorbidities undergoing pulmonary rehabilitation. Journal of Thoracic Disease, 11, S2238–S2253. https://doi.org/10.21037/jtd.2019.10.23CrossRefPubMedPubMedCentral

41.

Spencer, L. M., Alison, J. A., & McKeough, Z. J. (2010). Maintaining benefits following pulmonary rehabilitation: A randomised controlled trial. European Respiratory Journal, 35(3), 571–577. https://doi.org/10.1183/09031936.00073609CrossRef

42.

Thom, D. H., Willard-Grace, R., Tsao, S., Hessler, D., Huang, B., DeVore, D., Chirinos, C., Wolf, J., Donesky, D., Garvey, C., & Su, G. (2018). Randomized controlled trial of health coaching for vulnerable patients with chronic obstructive pulmonary disease [Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non‐U.S. Gov’t]. Annals of the American Thoracic Society, 15(10), 1159–1168. https://doi.org/10.1513/AnnalsATS.201806-365OCCrossRefPubMedPubMedCentral

43.

Wu, M., Zhou, L. Q., Li, S., Zhao, S., Fan, H. J., Sun, J. M., Li, X. N., Luo, J., Wang, A. Q., Wu, J. P., Li, X. Y., & Zhang, J. N. (2018). Efficacy of patients’ preferred exercise modalities in chronic obstructive pulmonary disease: A parallel-group, randomized, clinical trial [Journal Article; Multicenter Study; Randomized Controlled Trial]. Clinical respiratory journal, 12(4), 1581–1590. https://doi.org/10.1111/crj.12714CrossRef

44.

Xin, C., Xia, Z., Jiang, C., Lin, M., & Li, G. (2016). The impact of pharmacist-managed clinic on medication adherence and health-related quality of life in patients with COPD: A randomized controlled study. Patient Preference and Adherence, 10, 1197–1203.CrossRef

45.

Coultas, D., Frederick, J., Barnett, B., Singh, G., & Wludyka, P. (2005). A randomized trial of two types of nurse-assisted home care for patients with COPD. Chest, 128(4), 2017–2024. https://doi.org/10.1378/chest.128.4.2017CrossRefPubMed

46.

Ferrone, M., Masciantonio, M. G., Malus, N., Stitt, L., O’Callahan, T., Roberts, Z., Johnson, L., Samson, J., Durocher, L., Ferrari, M., Reilly, M., Griffiths, K., & Licskai, C. J. (2019). The impact of integrated disease management in high-risk COPD patients in primary care. NPJ Primary Care Respiratory Medicine, 29(1), 8. https://doi.org/10.1038/s41533-019-0119-9CrossRefPubMedPubMedCentral

47.

Hynninen, M. J., Bjerke, N., Pallesen, S., Bakke, P. S., & Nordhus, I. H. (2010). A randomized controlled trial of cognitive behavioral therapy for anxiety and depression in COPD. Respiratory Medicine, 104(7), 986–994. https://doi.org/10.1016/j.rmed.2010.02.020CrossRefPubMed

48.

Jarab, A. S., AlQudah, S. G., Khdour, M., Shamssain, M., & Mukattash, T. L. (2012). Impact of pharmaceutical care on health outcomes in patients with COPD. International Journal of Clinical Pharmacy, 34(1), 53–62. https://doi.org/10.1007/s11096-011-9585-zCrossRefPubMed

49.

Jonsdottir, H., Amundadottir, O. R., Gudmundsson, G., Halldorsdottir, B. S., Hrafnkelsson, B., Ingadottir, T. S., Jonsdottir, R., Jonsson, J. S., Sigurjonsdottir, E. D., & Stefansdottir, I. K. (2015). Effectiveness of a partnership-based self-management programme for patients with mild and moderate chronic obstructive pulmonary disease: A pragmatic randomized controlled trial. Journal of Advanced Nursing, 71(11), 2634–2649. https://doi.org/10.1111/jan.12728CrossRefPubMed

50.

Khdour, M. R., Kidney, J. C., Smyth, B. M., & McElnay, J. C. (2009). Clinical pharmacy-led disease and medicine management programme for patients with COPD. British Journal of Clinical Pharmacology, 68(4), 588–598. https://doi.org/10.1111/j.1365-2125.2009.03493.xCrossRefPubMedPubMedCentral

51.

Linneberg, A., Rasmussen, M., Buch, T. F., Wester, A., Malm, L., Fannikke, G., & Vest, S. (2012). A randomised study of the effects of supplemental exercise sessions after a 7-week chronic obstructive pulmonary disease rehabilitation program. Clinical Respiratory Journal, 6(2), 112–119.CrossRef

52.

McGeoch, G. R., Willsman, K. J., Dowson, C. A., Town, G. I., Frampton, C. M., McCartin, F. J., Cook, J. M., & Epton, M. J. (2006). Self-management plans in the primary care of patients with chronic obstructive pulmonary disease [Journal Article; Randomized Controlled Trial; Research Support, Non‐U.S. Gov’t]. Respirology (Carlton, Vic.), 11(5), 611–618. https://doi.org/10.1111/j.1440-1843.2006.00892.xCrossRef

53.

Tupper, O. D., Gregersen, T. L., Ringbaek, T., Brondum, E., Frausing, E., Green, A., & Ulrik, C. S. (2018). Effect of tele-health care on quality of life in patients with severe COPD: A randomized clinical trial. International Journal of Chronic Obstructive Pulmonary Disease, 13, 2657–2662. https://doi.org/10.2147/copd.S164121CrossRefPubMedPubMedCentral

54.

Wong, E. Y., Jennings, C. A., Rodgers, W. M., Selzler, A. M., Simmonds, L. G., Hamir, R., & Stickland, M. K. (2014). Peer educator vs. respiratory therapist support: Which form of support better maintains health and functional outcomes following pulmonary rehabilitation? Patient Education and Counseling, 95(1), 118–125. https://doi.org/10.1016/j.pec.2013.12.008CrossRefPubMed

55.

Ma, R. C., Yin, Y. Y., Wang, Y. Q., Liu, X., & Xie, J. (2020). Effectiveness of cognitive behavioural therapy for chronic obstructive pulmonary disease patients: A systematic review and meta-analysis. Complementary Therapies in Clinical Practice, 38, 101071. https://doi.org/10.1016/j.ctcp.2019.101071CrossRefPubMed

56.

Kruis, A. L., & Chavannes, N. H. (2010). Potential benefits of integrated COPD management in primary care. Monaldi Archives for Chest Disease, 73(3), 130–134. https://doi.org/10.4081/monaldi.2010.297CrossRefPubMed

57.

Arch, J. J., & Stanton, A. L. (2019). Examining the “usual” in usual care: A critical review and recommendations for usual care conditions in psycho-oncology. Support Care Cancer, 27(5), 1591–1600. https://doi.org/10.1007/s00520-019-04677-5CrossRefPubMedPubMedCentral

Titel: What conservative interventions can improve the long-term quality of life, depression, and anxiety of individuals with stable COPD? A systematic review and meta-analysis
Auteurs: Zejun Liang
Qian Wang
Chenying Fu
Rui Liu
Lu Wang
Gaiqin Pei
Lin Xu
Chengqi He
Quan Wei
Publicatiedatum: 12-08-2021
Uitgeverij: Springer International Publishing
Gepubliceerd in: Quality of Life Research / Uitgave 4/2022
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI: https://doi.org/10.1007/s11136-021-02965-4

Bohn Stafleu van Loghum

Deel dit onderdeel of sectie (kopieer de link)

Abstract

Purpose

Methods

Results

Conclusions

Log in om toegang te krijgen

Andere artikelen Uitgave 4/2022

BMI and dissatisfaction with life: contextual factors and socioemotional costs of obesity

Longitudinal measurement invariance of the international spinal cord injury quality of life basic data set (SCI-QoL-BDS) during spinal cord injury/disorder inpatient rehabilitation

A comparison of the influencing factors of chronic pain and quality of life between older Koreans and Korean–Americans with chronic pain: a correlational study

A scoping review on studies about the quality of life of informal caregivers of stroke survivors

Correction to: Exploration of a cultural-adaptation of the EQ-5D for Thai population: A “bolt-on” experiment

Identifying the content for an item bank and computerized adaptive testing system to measure the impact of age-related macular degeneration on health-related quality of life